Ab. Chang et al., EFFECT OF CAPSAICIN ON AIRWAY RESPONSIVENESS TO HYPERTONIC SALINE CHALLENGE IN ASTHMATIC AND NONASTHMATIC CHILDREN, Pediatric pulmonology, 23(6), 1997, pp. 412-416
Recurrent cough and asthma are common problems in children. In the eva
luation of children with recurrent cough, the sequential measurements
of airway responsiveness (AR) and capsaicin cough receptor sensitivity
may be useful. However, the effect of capsaicin on AR induced by an i
ndirect stimulus such as hypertonic saline (HS) is not known. Current
evidence suggests that a common pathway is involved in both capsaicin
and HS challenges. This study was designed to determine whether inhala
tion of capsaicin for the cough receptor sensitivity test before HS ch
allenge will alter AR of asthmatic and non-asthmatic children to that
challenge. Twenty-one children (12 asthmatics, 9 non-asthmatics; mean
age, 11.3 years) performed the HS challenge alone or 2 min after capsa
icin inhalation on 2 different days in random order. The end point of
the capsaicin inhalation was when greater than or equal to 5 coughs we
re stimulated from a single inhalation. The power of the study was >90
% at a significance level of 0.05.Capsaicin inhalation prior to HS cha
llenge did not alter the AR of normal children. In the asthmatic group
, the PD15 (provocation dose causing a fall in forced expiratory volum
e in 1 s of greater than or equal to 15% from the baseline) without pr
ior inhalation of capsaicin (mean, 2.44 +/- SEM 1.21 ml) was not signi
ficantly different from that when HS challenge was performed after cap
saicin inhalation (mean, 2.19 +/- SEM 0.83 ml). The mean of the differ
ence in log PD15 of the HS challenge with and without capsaicin was -0
.02 (95% Cl, -0.16, 0.12), i.e. within the equivalence range of the HS
challenge in children with asthma. We conclude that in normal and ast
hmatic children, capsaicin inhalation does not alter AR to HS; consequ
ently the capsaicin cough sensitivity test can be performed validly be
fore an HS challenge. (C) 1997 Wiley-Liss, Inc.